close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

SAN

80.24

-1.64%↓

UCB

237.4

-3.73%↓

SHL.DE

35.42

-1.69%↓

ARGX

666.6

-2.49%↓

VIE

35.59

+0.08%↑

SAN

80.24

-1.64%↓

UCB

237.4

-3.73%↓

SHL.DE

35.42

-1.69%↓

ARGX

666.6

-2.49%↓

VIE

35.59

+0.08%↑

SAN

80.24

-1.64%↓

UCB

237.4

-3.73%↓

SHL.DE

35.42

-1.69%↓

ARGX

666.6

-2.49%↓

VIE

35.59

+0.08%↑

SAN

80.24

-1.64%↓

UCB

237.4

-3.73%↓

SHL.DE

35.42

-1.69%↓

ARGX

666.6

-2.49%↓

VIE

35.59

+0.08%↑

SAN

80.24

-1.64%↓

UCB

237.4

-3.73%↓

SHL.DE

35.42

-1.69%↓

ARGX

666.6

-2.49%↓

VIE

35.59

+0.08%↑

Strona główna・Stock List・Merck KGaA
Search

Merck KGaA

Closed

SectorHealthcare

111.65

Buy

Price update 24 kwi 2026, 15:29 UTC

BuySell

Overview

Share price change

24h

Current

Min

111.55

Max

112.05

Key metrics

By Trading Economics

Income

250M

902M

Sales

63M

5.3B

Dividend yield

1.34

Profit margin

16.961

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+23.16% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

2.24%

Next Earnings

13 maj 2026

Market Stats

By TradingEconomics

Market Cap

98B

Previous open

111.65

Previous close

111.65

News Sentiment

By Acuity

16%

84%

71 / 348 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

121.15 / 123.55 Support & Resistance

Merck KGaA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

5 mar 2026, 06:28 UTC

Earnings

Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings

DJ

Read

13 lis 2025, 13:40 UTC

Earnings

Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update

DJ

Read

13 lis 2025, 06:24 UTC

Earnings

Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units

DJ

Read

1 kwi 2026, 12:06 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA Completes Acquisition of JSR Life Sciences' Chromatography Business

DJ

Read

5 mar 2026, 08:40 UTC

Market Talk

Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Sales EUR20B-EUR21B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Adj EPS EUR8.34

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA Keeps Dividend at EUR2.20 a Share

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 After-Tax Profit EUR2.615B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Sales EUR21.1B

DJ

Read

5 mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Ebitda Before Special Items EUR6.11B

DJ

Read

12 lut 2026, 15:20 UTC

Earnings

Sanofi Shares Fall After CEO Change -- Update

DJ

Read

20 sty 2026, 09:54 UTC

Market Talk
Acquisitions, Mergers, Takeovers

DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk

DJ

Read

13 lis 2025, 07:57 UTC

Market Talk
Earnings

Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Says Guidance Midpoint Remains Unchanged

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Organic Sales Growth of Around 3%

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA 3Q After-Tax Profit EUR898M

DJ

Read

13 lis 2025, 06:00 UTC

Earnings

Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors

DJ

Read

Peer Comparison

Price change

Merck KGaA Forecast

Price Target

By TipRanks

23.16% upside

12 Months Forecast

Average 138 EUR  23.16%

High 152 EUR

Low 112 EUR

Based on 8 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Based on 8 analysts giving stock ratings to Merck KGaA - Dist in the past 3 months.

Technical Score

By Trading Central

121.15 / 123.55Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Neutral Evidence

The bullish and bearish events are balanced.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

71 / 348 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck KGaA

There is no Profile data available for MRK.BE.

Other stocks from the sector

SAN

Sanofi SA

80.24

↓-1.64%

UCB

UCB SA

237.4

↓-3.73%

SHL.DE

Siemens Healthineers AG

35.42

↓-1.69%

ARGX

Argenx SE

666.6

↓-2.49%

VIE

Veolia Environnement SA.

35.59

↑ +0.08%
help-icon Live chat